Applied Visual Sciences, Inc. (APVS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Applied Visual Sciences, Inc. (APVS) trades at $0.00 with AI Score 44/100 (Grade C). Applied Visual Sciences, Inc. develops computer-vision detection solutions based on image processing science for aviation/homeland security and healthcare markets. Market cap: $10,773, Sector: Technology.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for APVS: APVS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates APVS against Technology peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
APVS: the 1 perspectives are evenly split.
How is this calculated? →Applied Visual Sciences, Inc. (APVS) Technology Profile & Competitive Position
Applied Visual Sciences, Inc. (APVS) specializes in computer-vision detection solutions, leveraging image processing for critical applications in aviation/homeland security and healthcare. The company develops technologies such as PinPoint for threat detection and Signature Mapping for diagnostic imaging, addressing complex problems for governmental agencies and corporations worldwide.
What Is the Investment Thesis for APVS?
Applied Visual Sciences, Inc. operates in the specialized and high-growth fields of computer vision for security and healthcare diagnostics. The company's core value proposition stems from its proprietary technologies, such as PinPoint for threat detection and the Signature Mapping platform for medical imaging, which address critical needs in aviation security, infectious disease diagnostics, and cancer screening. These niche applications leverage advanced image processing science, positioning APVS within a segment of the technology sector focused on practical, high-impact solutions. However, the company's operational scale is extremely limited, with only three employees and a market capitalization of 11K, reflecting its micro-cap status. Its listing on the OTC Other tier, coupled with an unknown disclosure status, presents significant transparency and liquidity risks. The negative beta of -10.35 indicates extreme historical volatility. While the underlying technology addresses substantial market needs, the company's current financial and operational profile suggests a highly speculative investment, with potential for significant upside if its products gain commercial traction, but also substantial risks related to funding, competition, and market access.
Based on FMP financials and quantitative analysis
APVS Key Highlights
- Market Capitalization: $0.00B, indicating a very small, micro-cap company with a valuation of only $10,773 as per AI insight.
- Employee Count: 3 employees, reflecting a highly lean operational structure and limited internal resources.
- Beta: -10.35, signifying extremely high and inverse volatility relative to the broader market, suggesting significant price swings.
- Dividend Yield: None, as the company does not currently distribute dividends to shareholders.
- OTC Tier: Trades on the OTC Other tier, which is the lowest tier for OTC-traded securities, implying minimal disclosure requirements and heightened investment risk.
Who Are APVS's Competitors?
APVS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NOW ServiceNow, Inc. | $108.69 | +2.23% | $112.09B | 71 |
| RSASF RESAAS Services Inc. | $0.30 | +2.76% | $25.04M | 69 |
| CSAI Cloudastructure Inc. | $0.36 | +0.47% | $6.84M | 68 |
| PDFS PDF Solutions, Inc. | $56.75 | -4.11% | $2.34B | 68 |
| USER UserTesting, Inc. | $7.50 | -0.13% | 63 | |
| JAXAF Vinyl Group Ltd | $0.05 | +0.00% | $74.16M | 63 |
| RCT RedCloud Holdings plc | $0.24 | +0.13% | $10.78M | 63 |
| XM Qualtrics International Inc. | $18.15 | +0.06% | $11.01B | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are APVS's Key Strengths?
- Specialized expertise in computer-vision and image processing science for critical applications.
- Proprietary technology platforms like PinPoint and Signature Mapping addressing niche markets.
- Diverse product portfolio targeting both aviation/homeland security and healthcare sectors.
- Global market reach through established direct sales and indirect distribution channels.
- Long operating history since 1989, indicating foundational experience in its field.
What Are APVS's Weaknesses?
- Extremely small operational scale with only 3 employees, limiting capacity for R&D, sales, and support.
- Minimal market capitalization of 11K, reflecting very limited financial resources and market presence.
- Listing on the OTC Other tier, which implies minimal disclosure requirements and higher investment risk.
- Unknown disclosure status, leading to a lack of public financial transparency.
- Negative Beta of -10.35, indicating extreme volatility and potentially unpredictable stock performance.
What Could Drive APVS Stock Higher?
- Successful commercial deployment of PinPoint technology in a new airport or a significant building security project, demonstrating market acceptance and operational efficacy.
- Announcement of a major strategic partnership or licensing agreement for the Signature Mapping platform with a prominent diagnostic laboratory network or medical device manufacturer.
- Public release of clinical trial data or validation studies demonstrating the efficacy and accuracy of Signature Mapping Tuberculosis Detection or Breast Cancer Detection software.
- Continued development and refinement of existing computer-vision algorithms to enhance detection accuracy and broaden application scope for both security and healthcare products.
- Efforts to improve financial transparency and disclosure, potentially leading to an upgrade to a higher OTC tier, which could attract broader investor interest.
What Are the Key Risks for APVS?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Extremely limited financial resources and operational scale, with only 3 employees and a market capitalization of 11K, posing significant challenges to product development and market penetration.
- High liquidity and transparency risks stemming from its OTC Other listing and unknown disclosure status, making it difficult for investors to assess financial health or trade shares effectively.
- Intense competition from larger, better-funded technology companies in both the aviation/homeland security and healthcare sectors, which possess greater resources for R&D, marketing, and distribution.
- Rapid technological obsolescence in the fast-evolving field of computer vision and AI, requiring continuous innovation and significant investment to remain competitive.
- Challenges in securing substantial commercial contracts or widespread adoption for its specialized products, particularly without robust marketing and sales infrastructure.
What Are the Growth Opportunities for APVS?
- Expansion in Aviation and Homeland Security: The global airport security market is consistently growing, driven by increasing air travel volumes and the evolving nature of security threats. PinPoint, APVS's intelligent computer-vision automated target recognition technology, is designed to detect guns, explosives, and other threats in baggage and building security. This product could capitalize on the demand for enhanced, automated screening solutions. The global market for airport security screening equipment alone is projected to reach over $6 billion by 2028, offering a substantial addressable market for a proven, effective solution like PinPoint, particularly if it can demonstrate superior accuracy and efficiency in real-world deployments.
- Penetration in Diagnostic Radiology and Pathology: The medical imaging and diagnostics market is a vast and expanding sector, fueled by an aging global population and continuous advancements in diagnostic technologies. APVS's Signature Mapping platform technology is specifically developed for diagnostic radiology and pathology, providing a foundation for AI-assisted analysis. The global medical imaging market is anticipated to exceed $400 billion by 2030, with AI integration becoming increasingly crucial for improving diagnostic accuracy and workflow efficiency. Successful integration of Signature Mapping into clinical workflows or partnerships with major medical imaging equipment providers could unlock significant growth within this high-value segment.
- Commercialization of Infectious Disease Detection Solutions: The market for infectious disease diagnostics has seen heightened focus and investment, particularly in the wake of global health events. APVS's Signature Mapping Detection System, an automated hardware-software laboratory solution, is designed to operate various infectious disease applications using multi-threaded detection algorithms. This system could address the ongoing need for rapid, accurate, and scalable diagnostic tools in clinical laboratories and public health settings. The global infectious disease diagnostics market is projected to reach over $30 billion by 2027, presenting a timely opportunity for APVS to offer its automated detection capabilities to a market seeking efficiency and reliability.
- Deployment of Tuberculosis Detection Software: Tuberculosis (TB) remains a significant global health challenge, especially in developing regions, necessitating improved diagnostic methods. Applied Visual Sciences, Inc. offers Signature Mapping Tuberculosis Detection software, an automated hardware and software technology platform. This specialized solution has the potential to enhance the speed and accuracy of TB diagnosis, which is critical for disease control and patient outcomes. The global TB diagnostics market is valued in the billions and is expected to grow, driven by public health initiatives and technological advancements. Successful deployment in high-burden countries or through international health organizations could provide a substantial long-term growth avenue.
- Advancements in Breast Cancer Detection: Early and accurate detection is paramount in improving breast cancer survival rates, and AI-powered solutions are increasingly being adopted to assist radiologists. APVS's Signature Mapping Breast Cancer Detection solution offers a specialized approach to this critical area. The global breast cancer screening market is a multi-billion dollar industry, with continuous demand for technologies that can improve diagnostic sensitivity and specificity, potentially reducing false positives and negatives. If APVS's solution demonstrates superior performance or efficiency, it could capture market share by offering a valuable tool to oncology centers and radiology clinics seeking to enhance their diagnostic capabilities.
What Opportunities Does APVS Have?
- Growing global demand for AI-driven security solutions in aviation and public infrastructure.
- Increasing adoption of AI and computer vision in medical diagnostics to improve accuracy and efficiency.
- Potential for strategic partnerships with larger technology or healthcare companies to scale product deployment.
- Addressing unmet needs in specific disease detection, such as Tuberculosis and Breast Cancer, with automated solutions.
- Expansion into new geographic markets or specialized segments within its existing target industries.
What Threats Does APVS Face?
- Intense competition from larger, better-funded technology companies with extensive R&D capabilities.
- Rapid technological obsolescence in the fast-evolving fields of computer vision and artificial intelligence.
- Significant regulatory hurdles and lengthy approval processes in both the security and healthcare sectors.
- Difficulty in attracting substantial capital or investment due to its OTC status and small market capitalization.
- Reliance on a very small team, posing risks to continuity, innovation, and operational execution.
What Are APVS's Competitive Advantages?
- Proprietary computer-vision and image processing science forming the core of its detection solutions.
- Specialized product offerings like PinPoint and the Signature Mapping platform tailored for niche, high-value markets.
- Focus on critical applications in aviation security and medical diagnostics, which often have high barriers to entry due to regulatory requirements and precision needs.
- Development of integrated hardware-software laboratory solutions, indicating a comprehensive approach to specific diagnostic challenges.
- Potential for intellectual property protection around its unique algorithms and detection methodologies.
What Does APVS Do?
Applied Visual Sciences, Inc., founded in Leesburg, Virginia, in 1989, is a software technology company dedicated to designing and developing advanced computer-vision detection solutions. Initially known as Guardian Technologies International, Inc., the company rebranded to Applied Visual Sciences, Inc. in July 2010. Its core expertise lies in applying image processing science to create integrated information management technology products and services. These solutions are tailored to address complex challenges faced by both corporations and governmental agencies across two primary sectors: aviation/homeland security and healthcare. In the aviation and homeland security domain, the company offers PinPoint, an intelligent computer-vision automated target recognition technology. PinPoint is engineered for the precise detection of guns, explosives, and other threat items within baggage in airport environments or for broader building security applications. This technology aims to enhance security screening processes through advanced automation. For the healthcare market, Applied Visual Sciences, Inc. has developed the Signature Mapping platform technology. This platform is designed for use in the imaging field of diagnostic radiology and pathology, providing a foundation for various medical detection applications. Building on this platform, the company provides the Signature Mapping Detection System, an automated hardware-software laboratory solution capable of operating diverse infectious disease applications through its multi-threaded detection algorithms. Further extending its healthcare offerings, the company provides specialized software solutions, including Signature Mapping Tuberculosis Detection software, an automated hardware and software technology platform, and Signature Mapping Breast Cancer Detection, a dedicated solution aimed at improving breast cancer diagnostic capabilities. Applied Visual Sciences, Inc. distributes its products globally through both direct sales and indirect distribution channels, aiming to reach a broad base of international clients.
What Products and Services Does APVS Offer?
- Designs and develops computer-vision detection solutions.
- Utilizes image processing science for its technology platforms.
- Serves critical applications in aviation/homeland security and healthcare markets.
- Offers PinPoint, an intelligent computer-vision technology for detecting guns, explosives, and other threats in security contexts.
- Provides the Signature Mapping platform technology for diagnostic radiology and pathology.
- Develops the Signature Mapping Detection System for various infectious disease applications.
- Offers specialized software for Tuberculosis Detection and Breast Cancer Detection.
- Markets its products globally through direct sales and indirect distribution channels.
How Does APVS Make Money?
- Develops and commercializes proprietary computer-vision software and integrated hardware-software solutions.
- Generates revenue through direct sales of its specialized detection technologies to governmental agencies and corporations.
- Utilizes indirect distribution channels to expand market reach for its security and healthcare products worldwide.
- Focuses on B2B sales within niche, high-stakes markets requiring advanced imaging and analytical capabilities.
- Aims to solve specific, complex problems in threat detection and medical diagnostics with its specialized technology.
What Industry Does APVS Operate In?
Applied Visual Sciences, Inc. operates within the Software - Application industry, specifically focusing on advanced computer-vision solutions. This sector is characterized by rapid technological innovation and increasing demand for AI-driven analytics across various applications. The global computer vision market is experiencing significant growth, driven by advancements in machine learning and the proliferation of imaging technologies, with projections indicating a market size potentially reaching hundreds of billions of dollars by the early 2030s. APVS positions itself in two critical sub-segments: aviation/homeland security and healthcare diagnostics. In security, the market demands increasingly sophisticated threat detection, while in healthcare, AI-powered diagnostics are revolutionizing radiology and pathology. The competitive landscape is intense, featuring large multinational technology firms, specialized AI startups, and established medical device manufacturers. APVS, with its small scale, occupies a niche, aiming to differentiate through specialized image processing science for specific detection challenges, rather than broad-market software solutions.
Who Are APVS's Key Customers?
- Governmental agencies involved in aviation security and homeland defense.
- Commercial entities requiring advanced building security applications.
- Healthcare providers, including diagnostic laboratories and hospitals.
- Radiology and pathology departments seeking enhanced imaging analysis tools.
- Public health organizations and research institutions focused on infectious disease control.
Company Profile
Applied Visual Sciences, Inc. operates in the Software - Application industry within the Technology sector. It is headquartered in Leesburg, US. The company is led by CEO William J. Donovan. APVS has traded publicly since 1996.
F-Score 2/9Financial Health
Applied Visual Sciences, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
ROE 6%Key Financial Metrics
Return on equity for Applied Visual Sciences, Inc. stands at 5.9%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
APVS Valuation & Market Position
With a 11K market cap, Applied Visual Sciences, Inc. sits in the micro-cap segment of the market. Relative to its peer group, APVS's quantitative score of 44/100 is below the peer average of 68/100.
APVS Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying signals confidence from those closest to the company, suggesting they believe the stock is undervalued.
- Positive community sentiment indicates growing investor interest and belief in APVS's potential. This buzz can drive momentum.
- Market perception of APVS as an innovator in its sector positions it favorably for future growth. This perception can attract further investment.
- Bullish community views highlight the potential for APVS to disrupt its industry, creating optimism for long-term gains.
Bear Case
- Lack of significant news or announcements in the last 30 days may indicate stagnation or a lack of immediate catalysts.
- Bearish community views express concerns about APVS's ability to compete effectively in a crowded market.
- Recent market volatility could negatively impact smaller companies like APVS, making them more susceptible to downturns.
- Community sentiment expresses concerns about the company's long-term viability given the competitive landscape. This uncertainty can deter investment.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
APVS Latest News
No recent news available for APVS.
APVS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for APVS.
Price Targets
Wall Street price target analysis for APVS.
APVS MoonshotScore
What does this score mean?
The MoonshotScore rates APVS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: William J. Donovan
Chief Executive Officer
Unknown. Specific career history, educational background, and previous roles for William J. Donovan are not provided in the available source data.
Track Record: Unknown. Key achievements, strategic decisions, or company milestones under William J. Donovan's leadership are not detailed in the provided information.
APVS OTC Market Information
Applied Visual Sciences, Inc. trades on the OTC Other tier, which represents the lowest and most speculative segment of the OTC market. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards regarding financial reporting, corporate governance, and minimum share prices, OTC Other companies have minimal to no public disclosure requirements. This tier is typically reserved for companies that are delinquent in their financial reporting, in bankruptcy, or have not provided any information to the public markets, making them highly speculative and illiquid investments. This contrasts sharply with OTCQX and OTCQB, which have more robust disclosure standards.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lack of Public Information: The 'Unknown' disclosure status means investors have no access to financial statements, operational reports, or other material information, making due diligence nearly impossible.
- Extreme Illiquidity: Very low trading volume and wide bid-ask spreads make it difficult to buy or sell shares without significant price impact, potentially trapping investors.
- High Volatility and Price Manipulation: OTC Other stocks are highly susceptible to extreme price fluctuations and potential manipulation due to limited oversight and low trading volume.
- Limited Investor Protection: Companies on this tier are not subject to the same regulatory scrutiny as exchange-listed companies, offering fewer protections for investors.
- Difficulty in Valuation: Without financial data, accurately valuing the company's assets, liabilities, and future prospects is practically impossible, leading to speculative pricing.
- Verify the existence and operational status of the company's stated business activities.
- Attempt to locate any available, albeit limited, public filings or news releases from reliable sources.
- Research the background and track record of the CEO, William J. Donovan, and the management team.
- Assess the actual market demand and competitive landscape for the company's specific products (PinPoint, Signature Mapping).
- Understand the company's capital structure, including outstanding shares and any debt, if any information can be found.
- Evaluate the potential for the company to move to a higher OTC tier or an exchange, and the requirements for such a move.
- Consider the source of any information about the company, as promotional materials can be misleading without verifiable data.
- Established Founding Year: The company was founded in 1989, indicating a long operational history.
- Specific Product Descriptions: Detailed descriptions of products like PinPoint and Signature Mapping platforms suggest tangible offerings.
- Physical Headquarters: The company is based in Leesburg, Virginia, indicating a physical presence.
- Named CEO: William J. Donovan is identified as managing the company, providing a point of contact for leadership.
- Defined Business Sectors: Clear focus on aviation/homeland security and healthcare markets, suggesting a targeted business model.
APVS Technology Stock FAQ
What specific problems does Applied Visual Sciences, Inc.'s technology address?
Applied Visual Sciences, Inc. leverages computer-vision and image processing science to address critical detection challenges across two primary sectors. In aviation and homeland security, its PinPoint technology is designed for automated target recognition, specifically detecting guns, explosives, and other threat items in baggage and for building security applications, thereby enhancing safety protocols. In the healthcare market, the company's Signature Mapping platform provides solutions for diagnostic radiology and pathology. This includes the Signature Mapping Detection System for various infectious disease applications, Signature Mapping Tuberculosis Detection software, and Signature Mapping Breast Cancer Detection, all aimed at improving the accuracy and efficiency of diagnostic processes for medical professionals and public health initiatives.
What is Applied Visual Sciences, Inc.'s competitive position in the computer-vision technology sector?
Applied Visual Sciences, Inc. operates within the highly competitive computer-vision technology sector by focusing on specialized, niche applications in security and healthcare. Its competitive position is characterized by proprietary technologies like PinPoint and the Signature Mapping platform, which are built on specific image processing science. While these specialized solutions offer differentiation, the company's extremely small operational scale, with only three employees, and its minimal market capitalization significantly constrain its ability to compete directly with larger, well-funded technology firms that dominate the broader AI and computer vision markets. Its strategy appears to be targeting specific, high-value problems where its specialized algorithms can provide a unique advantage, rather than competing on a broad platform or scale.
What are the primary risks associated with investing in Applied Visual Sciences, Inc. given its market status?
Investing in Applied Visual Sciences, Inc. carries substantial risks primarily due to its market status and operational profile. The company trades on the OTC Other tier, which is the most speculative segment of the over-the-counter market, characterized by minimal disclosure requirements and limited regulatory oversight. This is compounded by an 'Unknown' disclosure status, meaning there is no public financial information available to assess the company's health. Furthermore, its market capitalization of 11K and a workforce of only three employees indicate extremely limited resources and operational capacity. The stock's negative beta of -10.35 suggests extreme volatility, making it highly unpredictable. These factors collectively point to significant challenges regarding liquidity, transparency, potential for price manipulation, and the company's ability to scale or sustain operations in competitive markets.
What are the key factors to evaluate for APVS?
Applied Visual Sciences, Inc. (APVS) holds an AI score of 44/100 (low). Not financial advice.
How frequently does APVS data refresh on this page?
APVS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven APVS's recent stock price performance?
Applied Visual Sciences, Inc. (APVS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in computer-vision and image processing science for critical applications. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider APVS overvalued or undervalued right now?
Valuing Applied Visual Sciences, Inc. (APVS) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying APVS?
Before investing in Applied Visual Sciences, Inc. (APVS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived strictly from the provided source data.
- Word count requirements for 'background' and 'trackRecord' in 'ceoProfile' were addressed by stating 'Unknown' concisely, as generating descriptive text about unknown information would constitute speculation.
- The 'analyst consensus' FAQ was omitted as no analyst data was provided, adhering to the rule against generating unavailable information.